Clinical Effects of Altered Biomechanics in Knee Osteoarthritis
Lateral wedge orthotic shoe inserts
+ Standard orthotic shoe inserts
Arthrite+2
+ Maladies des Articulations
+ Maladies musculo-squelettiques
Étude thérapeutique
Résumé
Date de début de l'étude : 1 juin 2003
Date à laquelle le premier participant a commencé l'étude.Osteoarthritis (OA) is a chronic disease causing deterioration of the joint cartilage and the formation of bone spurs at the margins of the joints. Knee OA causes substantial pain, suffering, and disability, as well as enormous economic burden on the patient; unfortunately, treatment provides relief but not a cure. The majority of patients with symptomatic knee OA do not attain satisfactory long-term relief, even with recent advances in pain relievers. Analgesic treatment may relieve the pain but does not improve biomechanics and may even aggravate OA. Although OA is complex and not completely understood, disease onset and progression are at least partly related to responses by bone and cartilage to biomechanical loading. Devices that promote pressure reduction from the medial knee may provide pain relief while simultaneously protecting the joint from further degeneration; one such device is a lateral wedge orthotic shoe insert. When worn during weight-bearing activity, these inserts have been shown to reduce loading of the medial compartment and may provide pain relief. This study will evaluate the effectiveness of orthotic shoe inserts in controlling and relieving knee OA. The study will also assess improvements in loading biomechanics of the knee. This is a 3-year study. Patients will be randomly assigned to one of two groups; the first group will receive lateral wedge orthotic inserts and the second group will receive standard orthotic inserts. There will be 10 study visits during the course of the study. Patients will undergo X-rays and bone mineral density testing (DEXA) and 3 blood collections during the course of the study.
Protocole
Cette section fournit des détails sur le plan de l'étude, y compris la manière dont l'étude est conçue et ce qu'elle évalue.100 participants à inclure
Nombre total de participants que l'essai clinique vise à recruter.Traitement
Éligibilité
Les chercheurs recherchent des patients correspondant à une certaine description appelée critères d'éligibilité : état de santé général ou traitements antérieurs du patient.Tout sexe
Le sexe biologique des participants éligibles à s'inscrire.À partir de 25 ans
Tranche d'âge des participants éligibles à participer.Volontaires sains autorisés
Indique si les individus en bonne santé et ne présentant pas la condition étudiée peuvent participer.Conditions
Pathologie
Critères
Inclusion Criteria * Able and willing to give informed consent and to comply with the study protocol and follow-up instructions * Symptomatic and radiographic OA of the knee * Knee pain upon walking * Predominant medial compartment OA Exclusion Criteria * Knee flexion contracture of greater than 15 degrees or inability to walk without assistance * Predominant lateral compartment OA of either knee * Greater than 3 degree valgus or greater than 12 degree varus deformity of either knee, as defined by the mechanical axis * Clinically evident OA of the ankle or hip * Clinically significant intrinsic foot disease upon podiatric evaluation, including any foot condition that may be aggravated by wearing orthotics * Substantial obesity, defined as having body mass index (BMI) greater than 35 * Anticipation of surgery involving any joint of either lower extremity in the next 3 years * Habitual use of inappropriate shoewear that would interfere with adequate use of the orthotic inserts * Inflammatory arthropathy, such as rheumatoid arthritis, systemic lupus, or active gout * Chronic infection in any joint of the lower extremities * History of fracture of either lower extremity within 6 months of study entry * History of knee or hip arthroplasty or of surgical arthroscopy of either knee within 3 months of study entry * History of intra-articular injections (glucocorticoids or hyaluronic acid derivatives) in the index knee within 6 months of study entry * Pregnancy * Any medical condition which, in the opinion of the investigator, would render the patient unable to comply with the protocol
Plan de l'étude
Découvrez tous les traitements administrés dans cette étude, leur description détaillée et ce qu'ils impliquent.2 groupes d'intervention sont désignés dans cette étude
Cette étude ne comporte pas de groupe placebo.
Groupes de traitement
Groupe I
ExpérimentalGroupe II
Comparateur actifObjectifs de l'étude
Objectifs principaux
Objectifs secondaires
Centres d'étude
Ce sont les hôpitaux, cliniques ou centres de recherche où l'essai est conduit. Vous pouvez trouver le site le plus proche de vous ainsi que son statut.Cette étude comporte 1 site